Literature DB >> 7596216

Effects of growth hormone and prolactin immune development and function.

W J Murphy1, H Rui, D L Longo.   

Abstract

Growth hormone and prolactin are neuroendocrine hormones that exert numerous effects on immune system function and development. Several fundamental questions are addressed in this review. Do neuroendocrine hormones affect specific immune cell types? What is the physiological significance of these effects? Can these effects be exploited clinically? While it is clear that there are indeed significant interactions between the neuroendocrine and immune systems, there are relatively few examples with demonstrated physiological significance. Present studies indicate that growth hormone and prolactin may exert markedly different effects on immune cell types depending on their stage in differentiation. Recent emphasis has also been focussed on the use of these hormones or their antagonists clinically in the treatment of AIDS, cancer, and autoimmune disease states due to their pleiotropic effects and low toxicity after systemic administration. However, we do not yet have a clear picture of how the influence of neuroendocrine hormones may be used to favorably alter pathophysiologic processes affecting immune function and development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596216     DOI: 10.1016/0024-3205(95)00237-z

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 2.  [Effects of dopamine on cellular and humoral immune responses in septic patients].

Authors:  G Beck; C Hanusch; P Brinkkoetter; N Rafat; J Schulte; K van Ackern; B Yard
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

Review 3.  Non-pharmacologic interventions to improve the sleep of hospitalized patients: a systematic review.

Authors:  Ruth Tamrat; Minh-Phuong Huynh-Le; Madhav Goyal
Journal:  J Gen Intern Med       Date:  2013-10-10       Impact factor: 5.128

4.  Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene.

Authors:  N D Horseman; W Zhao; E Montecino-Rodriguez; M Tanaka; K Nakashima; S J Engle; F Smith; E Markoff; K Dorshkind
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

Review 5.  Milk-borne prolactin and neonatal development.

Authors:  L A Ellis; A M Mastro; M F Picciano
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

6.  Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells.

Authors:  Traci Galbaugh; Yvonne B Feeney; Charles V Clevenger
Journal:  Mol Cancer Res       Date:  2010-09-08       Impact factor: 5.852

7.  Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras.

Authors:  Jian Zhang; Rui Sun; Zhigang Tian
Journal:  Clin Vaccine Immunol       Date:  2006-11-01

8.  Effects of Freund's complete adjuvant on the diurnal rhythms of neuroendocrine processes and ornithine decarboxylase activity in various tissues of male rats.

Authors:  M Neidhart
Journal:  Experientia       Date:  1996-09-15

9.  Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors:  M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

10.  Hematologic neoplasias and acromegaly.

Authors:  Flavia Regina P Barbosa; Leonardo Vieira Neto; Giovanna Aparecida B Lima; Luiz Eduardo Wildemberg; Rodrigo Portugal; Monica R Gadelha
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.